Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Clinical trial NCT07582172 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07582172
Sponsor: City of Hope Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia With Complex Karyotype Myelodysplastic Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Recurrent Myelodysplastic Chronic Myelomonocytic Leukemia Recurrent Myelodysplastic Syndrome Recurrent Secondary Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Myelodysplastic Chronic Myelomonocytic Leukemia Refractory Myelodysplastic Syndrome Refractory Secondary Acute Myeloid Leukemia

Start date: 2027-04-05
Primary completion: 2029-04-05
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.